Policy· August 12, 2026 · 38 min read
IARC Group 1 Call on HCTZ, Voriconazole, Tacrolimus: Pharma & P&T Actions
By Ran Chen#FDA#Label Warnings#Formulary Strategy
Topic
Real-World Evidence
Claims data, registries, observational studies, post-launch evidence, and payer-relevant outcomes beyond pivotal trials.
Evidence· July 14, 2026 · 17 min read
H1 Antihistamines in FAERS: 925,032 Adverse-Event Reports
Evidence· July 13, 2026 · 16 min read
ADHD Medications in FAERS: 194,052 Adverse-Event Reports by the Numbers
Evidence· July 10, 2026 · 17 min read
Anticoagulant Adverse Events in FAERS: 244,000 Reports and Bleeding/HIT Profiles
Evidence· July 10, 2026 · 17 min read
Calcineurin Inhibitor Adverse Events in FAERS: 275,000 Reports and Key Safety Signals
Evidence· July 9, 2026 · 16 min read
Benzodiazepines in FAERS: Adverse Events, Dependence, and Safety Signals
Evidence· July 8, 2026 · 23 min read
Diuretic Adverse Events in FAERS: 763,000 Reports Across Three Sub-Classes
Evidence· July 8, 2026 · 28 min read
NSAID Adverse Events in FAERS: 1.5 Million Reports and the Non-Aspirin Signal Profile
Evidence· July 7, 2026 · 21 min read
Calcium Channel Blocker Adverse Events in FAERS: 619,000 Reports and Class-Wide Signals
Evidence· July 6, 2026 · 16 min read